223
Participants
Start Date
August 21, 2017
Primary Completion Date
January 14, 2019
Study Completion Date
April 23, 2019
4-OH tamoxifen
4-Hydroxytamoxifen (afimoxifene) gel
Placebo
An absorptive hydroalcoholic gel preparation of the same ingredients as BHR-700, but without 4-OHT.
University of Virginia Medical Park Northridge, Charlottesville
Carolina Women's Research and Wellness Center, Durham
Instituto Palacios Salud de La Mujer, Madrid
Coastal Carolina Research Center, Inc., Mt. Pleasant
South Florida Medical Research, Aventura
Physician Care Clinical Research, LLC, Sarasota
Lake OB-GYN Associates of Mid-Florida, Leesburg
Aventiv Research, Inc., Columbus
Private Practice - Gynecology, Frankfurt am Main
Mesa Obstetricians and Gynecologists/Cactus Clinical Research, Mesa
Visions Clinical Research, Tucson
Bosque Women Care/Cactus Clinical Research, Albuquerque
Affiliated Clinical Research, Inc., Las Vegas
USC-Keck Medical Center, Los Angeles
United Clinical Research, Beverly Hills
City of Hope, Duarte
Overlake Internal Medicine Associates, PS, Bellevue
Dedicated Women's Health Specialists, Puyallup
Center for Women's Health and Wellness, Plainsboro
Lead Sponsor
BHR Pharma, LLC
INDUSTRY